Gibson, Dunn & Crutcher represented Apogee Therapeutics, Inc. in the offering, and Cooley represented the underwriters. Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company, announced the...
Apogee Therapeutics’ $483 Million Common Stock Offering
Apogee Therapeutics’ Initial Public Offering
Gibson, Dunn & Crutcher LLP is advising Apogee Therapeutics, Inc. in the offering. Apogee Therapeutics, Inc. (Nasdaq: APGE) announced the pricing of its upsized initial public offering...